Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024868 <b>Size:</b> 559 KB

Director KERSTEN GEERT R 🟢 acquired 100.0K shares of CEL SCI CORP (CVM) at $1.38 Transaction Date: Aug 25, 2026 | Filing ID: 000008

SciSparc SPRC Notification

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041529 <b>Size:</b> 201 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024867 <b>Size:</b> 815 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0000950103-26-012896 <b>Size:</b> 138 KB

SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board

VCI Global Announces Galatron AI Factory, a Modular AI Data Center Platform with Roadmap to 500MW of Compute Capacity

Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024865 <b>Size:</b> 783 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024866 <b>Size:</b> 827 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024864 <b>Size:</b> 832 KB

20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity

Financial Statements and Related Announcement: Full Yearly Results

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer